BridgeMD
New treatment option for Frozen Shoulder
Official title The Combined Effect of Mulligan Mobilization, Pain Neuroscience-Based Training, and Core Stabilization Exercises in Frozen Shoulder Patients
ClinicalTrials.gov ID: NCT07667556
What this study is testing
- What it's testing
- The purpose of this randomized controlled study is to investigate the effects of a combined rehabilitation program consisting of Mulligan Mobilization with Movement (MWM), Pain Neuroscience Education (PNE), and core stabilization exercises in individuals with adhesive capsulitis (frozen shoulder). The main questions this study aims to answer are: Does the combination of Mulligan mobilization, Pain Neuroscience Education, and core stabilization exercises reduce pain in individuals with adhesive capsulitis?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Adults aged 18 to 65 years
- Diagnosis of adhesive capsulitis confirmed by an orthopedic surgeon or a physical medicine and rehabilitation physician
- Presence of shoulder pain and limitation of shoulder range of motion
- Ability to communicate verbally
- Ability to understand study procedures and educational content
You likely can't join if
- MMSE score below 24
- Severe cognitive impairment
- Severe psychiatric disorders
- Active infectious disease
- Active malignancy
- Uncontrolled cardiovascular disease
See the full eligibility criteria
- Adults aged 18 to 65 years
- Diagnosis of adhesive capsulitis confirmed by an orthopedic surgeon or a physical medicine and rehabilitation physician
- Presence of shoulder pain and limitation of shoulder range of motion
- Ability to communicate verbally
- Ability to understand study procedures and educational content
- Willingness to participate and provide written informed consent
- Mini-Mental State Examination (MMSE) score of 24 or higher
- Ability to attend treatment and assessment sessions regularly
- MMSE score below 24
- Severe cognitive impairment
- Severe psychiatric disorders
- Active infectious disease
- Active malignancy
- Uncontrolled cardiovascular disease
- Presence of a cardiac pacemaker
- Contraindications to transcutaneous electrical nerve stimulation (TENS)
- Neurological disorders that may affect participation or outcomes
- Systemic diseases that may interfere with the safe implementation of the intervention
- Inability to comply with the study protocol or attend scheduled sessions
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.